Medical Disorders
Resources
Basic InformationLookupsLatest News
Pfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollAnother Study Finds Pfizer, Moderna Shots Effective Against COVID VariantsLyme Disease Often Spotted at Later Stage in Black PatientsFDA Panel Supports Moderna Booster Shot for Older Adults, People at High RiskIs a Really Bad Flu Season on the Way?Climate Change Could Bring Rising Obesity RatesKids Can Carry High, Infectious Levels of COVID CoronavirusMore Than Half of COVID-19 Survivors Will Get 'Long COVID'One-Third of Americans With Arthritis Get No ExerciseDeath Threats, Trolling Common for Scientists Who Speak to Media About COVIDAHA News: The Differences and Similarities Between the Flu and COVID-19FDA Questions Strength of Johnson & Johnson's Booster Shot DataHelmets Can Saves Lives in ATV, Dirt Bike CrashesCancer Care Costs U.S. $156 Billion Per Year; Drugs a Major FactorFDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster ShotsAnti-Nausea Drug May Boost Survival for Some Cancer PatientsExpert Panel Backs Off Recommendation for Aspirin to Prevent Heart TroubleAccess to Top Drugs Makes the Difference for Black Lung Cancer PatientsRisk of COVID from Grocery Store Surfaces Very Low: Study
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Review of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: Fauci

HealthDay News
by By Cara Murez HealthDay Reporter
Updated: Sep 20th 2021

new article illustration

MONDAY, Sept. 20, 2021 (HealthDay News) – If Americans who received the Moderna or Johnson & Johnson coronavirus vaccines are dismayed by the lack of information on booster shots for them, their wait should end soon.

Data on booster shots for those vaccines is only a few weeks away from a review by the U.S. Food and Drug Administration, Dr. Anthony Fauci said Sunday during interviews on various television news programs.

"The actual data that we'll get [on] that third shot for the Moderna and second shot for the J&J is literally a couple to a few weeks away," Fauci said on the NBC News' "Meet the Press." "We're working on that right now to get the data to the FDA, so they can examine it and make a determination about the boosters for those people."

On Friday, an FDA advisory panel voted unanimously to recommend a booster shot of the Pfizer vaccine six months after the second dose for certain vulnerable Americans -- those aged 65 and older, anyone at high risk for severe illness, and people who have greater exposure to the virus because of their jobs. The FDA is expected to issue its decision on Pfizer booster shots this week, the Washington Post reported. The agency typically, though not always, follows the advice of its advisory panels.

Fauci acknowledged that the approximately 81 million Americans who received the Moderna or J&J vaccines may feel left out.

"We are definitely paying strong attention to both the J&J people and those who received a Moderna," said Fauci, who is director of the U.S. National Institute of Allergy and Infectious Diseases. "They're not being left behind by any means."

The process of rolling out booster shots is evolving, noted Fauci, who is 80 and plans to get a booster shot when it's approved.

"The one thing I think people need to realize is that data are coming in, literally, on a daily and weekly basis," Fauci explained. "They're going to continue to look at this, literally in real time. More data will be coming in on both safety for younger individuals, efficacy… So, the story is not over yet. I think people need to understand that. This is not the end of the story."

Fauci also addressed an announcement made last month by President Joe Biden, who said booster shots would be available starting Sept. 20 for all vaccinated Americans. In his announcement, Biden said people would get their third doses eight months after their second shots. At the time, Biden pointed to waning protection against infection after several months.

"The president was very clear, as was the medical group, when we said we are planning to do this," Fauci said on CNN's "State of the Union.

Fauci noted that the rollout of boosters was always conditional on an FDA review and that Biden made that clear when he first announced plans for booster shots.

Dr. Francis Collins, director of the U.S. National Institutes of Health, also weighed in on the booster debate during television morning show interviews on Sunday.

That the question of boosters has evolved over time shows that the process is working, Collins said, the Post reported. Collins would not say whether he thought everyone needed a third dose of a COVID-19 vaccine, but he did note that a decision on whether to extend booster eligibility beyond those recommended by the FDA panel on Friday would likely happen in the coming weeks.

"In a certain way… this is the way it ought to be," Collins said on CBS News' "Face the Nation." "Science sort of playing out in a very transparent way, looking at the data coming from multiple places, our country, other countries and trying to make the best decision for right now. That's what they did."

More information

The U.S. Centers for Disease Control and Prevention has more information on COVID-19 vaccines.


SOURCE: Washington Post




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net